Pyxant Labs Inc — Form D/A
Pyxant Labs Inc of COLORADO SPRINGS, CO, a company, filed a Form D amendment with the SEC on 2017-07-13. The offering totals $1.5M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-13
- Form: D/A
- Accession: 0001364214-17-000001
- Industry: Biotechnology
- Exemptions: 06b, 4a5
- Total offering: $1.5M
- Amount sold: $1.1M
- Remaining: $397K
- Minimum investment: $10K
- Investors: 17
- Date of first sale: 2016-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-258290
Issuer
- Name: Pyxant Labs Inc
- CIK: 0001364214
- Entity type: Corporation
- Jurisdiction: COLORADO
- Address: 4720 FORGE RD, COLORADO SPRINGS, CO, 80907
- Phone: 719-593-1165
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Lee A Daniel III | Director | Colorado Springs, CO |
| Maurice A Gaubatz | Director | Colorado Springs, CO |
| John A Gloriod | Director | Colorado Springs, CO |
| Dean P Stull | Director | Colorado Springs, CO |
| Maurice A Gaubatz | Executive Officer | Colorado Springs, CO |
| Randall H Guthrie | Executive Officer | Colorado Springs, CO |
| Jean A Pineault | Executive Officer | Colorado Springs, CO |
| Bruce Blankenship | Director | Colorado Springs, CO |
| John Gloriod | Director | Colorado Springs, CO |
| Dean Stull | Director | Colorado Springs, CO |
| Maurice Gaubatz | Director | Colorado Springs, CO |
| Maurice Gaubatz | Executive Officer | Colorado Springs, CO |
| Lee Daniel | Director | Colorado Springs, CO |
Other filings by this issuer (3)
More